Theoretically, PTEN (p.T321fs) mutation may lead to inadequate PTEN function with inhibition of the phosphorylation of PTEN on Tyr336 by RAK and focal adhesion kinase (FAK), and subsequent cancer progression [15–17]. Here, PTEN is linked to cancer.